Our results demonstrate that decorin-loaded microrods release decorin for up to a month and can significantly improve cardiac function and attenuate deleterious ventricular dilatation, cardiac fibrosis, and hypertrophy in chronic models of ischemia-reperfusion MI. The gene discussed is DCN; the disease is cardiac hypertrophy.